TipRanks
Hangzhou Tigermed Consulting Co., Ltd. Class H (DE:5HZ1)
FRANKFURT:5HZ1
Germany Market
5HZ1
Hangzhou Tigermed Consulting Co., Ltd. Class H
RESEARCH TOOLSreports

Hangzhou Tigermed Consulting Co., Ltd. Class H (5HZ1) Ratios

2 Followers

Hangzhou Tigermed Consulting Co., Ltd. Class H Ratios

DE:5HZ1's free cash flow for Q2 2026 was ¥0.27. For the 2026 fiscal year, DE:5HZ1's free cash flow was decreased by ¥ and operating cash flow was ¥0.12. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 2.49 2.18 1.72 2.74 2.98
Quick Ratio
 2.46 2.16 1.71 2.74 2.97
Cash Ratio
 0.77 0.63 0.56 1.79 2.11
Solvency Ratio
 0.07 0.30 0.16 0.45 0.48
Operating Cash Flow Ratio
 0.53 0.39 0.30 0.28 0.36
Short-Term Operating Cash Flow Coverage
 3.42 2.19 0.57 0.58 0.73
Net Current Asset Value
¥ 1.82B¥ 2.07B¥ 1.69B¥ 6.12B¥ 6.34B
Leverage Ratios
Debt-to-Assets Ratio
 0.08 0.05 0.09 0.10 0.10
Debt-to-Equity Ratio
 0.12 0.07 0.13 0.13 0.14
Debt-to-Capital Ratio
 0.11 0.07 0.11 0.12 0.13
Long-Term Debt-to-Capital Ratio
 0.08 0.03 0.02 0.02 0.01
Financial Leverage Ratio
 1.43 1.35 1.39 1.41 1.40
Debt Service Coverage Ratio
 1.39 2.03 0.44 1.23 1.36
Interest Coverage Ratio
 2.27 11.15 4.70 20.74 31.05
Debt to Market Cap
 0.05 0.03 0.09 0.09 0.03
Interest Debt Per Share
 3.44 1.82 3.21 3.41 3.34
Net Debt to EBITDA
 0.19 -0.21 0.51 -1.58 -1.72
Profitability Margins
Gross Profit Margin
25.85%27.41%33.95%38.58%39.64%
EBIT Margin
17.61%16.01%12.20%35.33%37.66%
EBITDA Margin
21.00%20.79%17.11%39.47%41.40%
Operating Profit Margin
16.39%14.77%10.06%33.68%36.45%
Pretax Profit Margin
6.59%14.68%10.06%33.70%36.49%
Net Profit Margin
1.25%12.99%6.14%27.42%28.32%
Continuous Operations Profit Margin
3.52%11.78%6.78%29.12%32.06%
Net Income Per EBT
19.03%88.50%60.97%81.37%77.61%
EBT Per EBIT
40.19%99.39%100.01%100.06%100.12%
Return on Assets (ROA)
0.33%3.13%1.41%6.82%7.31%
Return on Equity (ROE)
0.44%4.24%1.96%9.63%10.25%
Return on Capital Employed (ROCE)
4.74%3.95%2.66%9.74%10.89%
Return on Invested Capital (ROIC)
2.49%3.11%1.66%7.81%8.88%
Return on Tangible Assets
0.38%3.61%1.61%7.63%8.15%
Earnings Yield
0.19%2.70%1.62%7.31%2.91%
Efficiency Ratios
Receivables Turnover
 1.74 1.66 1.67 2.04 2.34
Payables Turnover
 17.02 13.36 16.95 18.19 27.08
Inventory Turnover
 82.38 119.50 136.47 193.84 192.62
Fixed Asset Turnover
 4.59 4.00 3.92 5.01 5.34
Asset Turnover
 0.26 0.24 0.23 0.25 0.26
Working Capital Turnover Ratio
 1.89 2.29 1.34 1.01 0.90
Cash Conversion Cycle
 193.37 195.35 200.01 161.02 144.56
Days of Sales Outstanding
 210.37 219.61 218.87 179.20 156.15
Days of Inventory Outstanding
 4.43 3.05 2.67 1.88 1.89
Days of Payables Outstanding
 21.44 27.31 21.53 20.06 13.48
Operating Cycle
 214.81 222.66 221.54 181.09 158.04
Cash Flow Ratios
Operating Cash Flow Per Share
 1.69 1.30 1.27 1.33 1.57
Free Cash Flow Per Share
 1.43 1.05 0.86 0.97 1.05
CapEx Per Share
 0.26 0.25 0.41 0.36 0.52
Free Cash Flow to Operating Cash Flow
 0.84 0.81 0.67 0.73 0.67
Dividend Paid and CapEx Coverage Ratio
 4.60 2.00 1.10 1.27 1.44
Capital Expenditure Coverage Ratio
 6.43 5.22 3.08 3.67 3.03
Operating Cash Flow Coverage Ratio
 0.60 0.76 0.42 0.41 0.48
Operating Cash Flow to Sales Ratio
 0.19 0.16 0.17 0.16 0.19
Free Cash Flow Yield
2.77%2.75%2.96%3.02%1.32%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 730.00 37.10 61.55 13.69 34.32
Price-to-Sales (P/S) Ratio
 5.91 4.81 3.79 3.75 9.72
Price-to-Book (P/B) Ratio
 2.51 1.57 1.21 1.32 3.52
Price-to-Free Cash Flow (P/FCF) Ratio
 36.15 36.40 33.79 33.13 75.77
Price-to-Operating Cash Flow Ratio
 34.60 29.42 22.81 24.09 50.73
Price-to-Earnings Growth (PEG) Ratio
 -9.55 0.31 -0.77 15.88 -1.15
Price-to-Fair Value
 2.51 1.57 1.21 1.32 3.52
Enterprise Value Multiple
 28.34 22.95 22.66 7.94 21.75
Enterprise Value
 43.39B 32.60B 25.60B 23.12B 63.81B
EV to EBITDA
 28.34 22.95 22.66 7.94 21.75
EV to Sales
 5.95 4.77 3.88 3.13 9.01
EV to Free Cash Flow
 36.40 36.07 34.57 27.64 70.21
EV to Operating Cash Flow
 30.74 29.15 23.34 20.10 47.01
Tangible Book Value Per Share
 23.22 23.76 23.70 24.64 22.97
Shareholders’ Equity Per Share
 23.29 24.34 23.90 24.30 22.65
Tax and Other Ratios
Effective Tax Rate
 0.47 0.20 0.33 0.14 0.12
Revenue Per Share
 8.72 7.94 7.63 8.53 8.19
Net Income Per Share
 0.11 1.03 0.47 2.34 2.32
Tax Burden
 0.19 0.89 0.61 0.81 0.78
Interest Burden
 0.37 0.92 0.82 0.95 0.97
Research & Development to Revenue
 0.04 0.04 0.04 0.04 0.03
SG&A to Revenue
 0.13 0.05 0.05 0.04 0.04
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 <0.01
Income Quality
 15.45 1.39 2.45 0.57 0.60
Currency in CNY